Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Brain activation changes during locomotion in middle-aged to older adults with multiple sclerosis.
The 11-year long-term follow-up study from the randomized BENEFIT CIS trial.
A Review of Possible Herbal Treatment in Multiple Sclerosis in Traditional Persian Medicine.
Impact of the Great East Japan Earthquake in 2011 on MS and NMOSD: a study in Sendai, Japan.
Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis.
Effect of cognitive behavioral therapy on MS patients' quality of life. A multi-centre controlled trial.
Histological Basis of Laminar MRI Patterns in High Resolution Images of Fixed Human Auditory Cortex.
Differential Expression of Glucocorticoid Receptor Noncoding RNA Repressor Gas5 in Autoimmune and Inflammatory Diseases.
Structural determinant for inducing RORgamma specific inverse agonism triggered by a synthetic benzoxazinone ligand.
Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up.
Relationship between Visual Dysfunction and Retinal Changes in Patients with Multiple Sclerosis.
Proton-gated Ca(2+)-permeable TRP channels damage myelin in conditions mimicking ischaemia.
Recent progress on the role of GABAergic neurotransmission in the pathogenesis of Alzheimer's disease.
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
Low serum uric acid levels in patients with multiple sclerosis and neuromyelitis optica: An updated meta-analysis.
The Changing Landscape of Childhood Inflammatory Central Nervous System Disorders.
The Effect of Orem's Self-Care Model on Fatigue in Patients With Multiple Sclerosis: A Single Blind Randomized Clinical Trial Study.
Altered tumor growth factor beta mRNA expression is associated with thymectomy-related clinical remission in myasthenia gravis.
Immunoadsorption in patients with neuromyelitis optica spectrum disorder.
Altered Expression of Specific Transcription Factors of Th17 (RORγt, RORα) and Treg Lymphocytes (FOXP3) by Peripheral Blood Mononuclear Cells from Patients with Multiple Sclerosis.
Intravascular lymphoma mimicking multiple sclerosis.
Reg-2, A Downstream Signaling Protein in the Ciliary Neurotrophic Factor Survival Pathway, Alleviates Experimental Autoimmune Encephalomyelitis.
Drugs for multiple sclerosis.
Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells.
The Effectiveness of Group Cognitive Behavioral Therapy in Treating Obsessive-Compulsive Disorder in Women with Multiple Sclerosis (MS): A randomized double-blind controlled trial.
Pages
« first
‹ previous
…
765
766
767
768
769
770
771
772
773
…
next ›
last »